Abstract RF01-01: SERENA-3: A Randomized Pre-Surgical Window of Opportunity Study Assessing Dose and Duration of Camizestrant Treatment in Post-Menopausal Women with ER-positive, HER2-negative Primary Breast Cancer
Cancer Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined